The Europe pulmonary function testing systems market was valued at US$ 77.72 million in 2022 and is expected to reach US$ 112.11 million by 2028; it is estimated to register a CAGR of 6.3% from 2022 to 2028.
Incidences of Occupational Lung Diseases Fuels Europe Pulmonary Function Testing Systems Market
Rising incidences of occupational lung disease are among the most influential factors accelerating the demand for pulmonary function testing systems. A pulmonary function testing system helps determine occupational lung disease among workers. As spirometry testing is intended for both screening and clinical evaluations at the workplace, it is performed in small clinical practices, small-sized industries, and multiple plant medical departments within an industry. Such an effective practice at the workplace has significant demand for pulmonary function testing systems.
Europe Pulmonary Function Testing Systems Market Overview
The Europe pulmonary function testing systems market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The market growth is attributed to the surging number of patients suffering from COPD and asthma and the growing number of visits to independent physician clinics to diagnose these diseases. Also, improvements in healthcare infrastructure and the presence of major market players in the region are a few factors increasing the demand for PFT systems in Europe.
Europe Pulmonary Function Testing Systems Market Revenue and Forecast to 2028 (US$ Million)
Europe Pulmonary Function Testing Systems Market Segmentation
The Europe pulmonary function testing systems market is segmented on the basis of type, test type, component, application, end user, and country.
Based on type, the Europe pulmonary function testing systems market is bifurcated into cart-based PFT systems and stationery PFT systems. The cart-based PFT systems segment held a larger share of the Europe pulmonary function testing systems market in 2022.
Based on test type, the Europe pulmonary function testing systems market is segmented into spirometry, lung volume, gas exchange testing, maximum voluntary ventilation, oxygen titration test, and others. The spirometry segment held the largest share of the Europe pulmonary function testing systems market in 2022.
Based on component, the Europe pulmonary function testing systems market is segmented into hardware, software, and services. The hardware segment held the largest share of the Europe pulmonary function testing systems market in 2022.
Based on application, the Europe pulmonary function testing systems market is segmented into chronic obstructive pulmonary disorder, asthma, chronic shortness of breath, restrictive lung disease, and others. The chronic obstructive pulmonary disorder segment held the largest share of the Europe pulmonary function testing systems market in 2022.
Based on end-user, the Europe pulmonary function testing systems market is segmented into hospitals, specialty clinics, and diagnostic laboratories. The hospitals segment held the largest share of the Europe pulmonary function testing systems market in 2022.
Based on country, the Europe pulmonary function testing systems market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the share of the Europe pulmonary function testing systems market in 2022.
COSMED Srl, KoKo PFT Ltd, MGC Diagnostics Corp, ndd Medical Technologies Inc, PulmOne Advanced Medical Devices Ltd, Schiller AG, and Vyaire Medical Inc are the leading companies operating in the Europe pulmonary function testing systems market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 77.72 Million |
| Market Size by 2028 | US$ 112.11 Million |
| CAGR (2022 - 2028) | 6.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Pulmonary Function Testing Systems Market is valued at US$ 77.72 Million in 2022, it is projected to reach US$ 112.11 Million by 2028.
As per our report Europe Pulmonary Function Testing Systems Market, the market size is valued at US$ 77.72 Million in 2022, projecting it to reach US$ 112.11 Million by 2028. This translates to a CAGR of approximately 6.3% during the forecast period.
The Europe Pulmonary Function Testing Systems Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Pulmonary Function Testing Systems Market report:
The Europe Pulmonary Function Testing Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Pulmonary Function Testing Systems Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Pulmonary Function Testing Systems Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Pulmonary Function Testing Systems Market
